HealthEquity (HQY) Expected to Announce Quarterly Earnings on Wednesday

HealthEquity (NASDAQ:HQY) is expected to release its Q3 2026 results after the market closes on Wednesday, December 3rd. Analysts expect the company to announce earnings of $0.90 per share and revenue of $320.9240 million for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earningreport for the latest details on the call scheduled for Wednesday, December 3, 2025 at 4:30 PM ET.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $325.80 million during the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. On average, analysts expect HealthEquity to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

HealthEquity Stock Down 2.6%

Shares of HealthEquity stock opened at $102.41 on Tuesday. The stock has a market capitalization of $8.82 billion, a price-to-earnings ratio of 62.07, a PEG ratio of 1.36 and a beta of 0.47. HealthEquity has a twelve month low of $74.07 and a twelve month high of $116.65. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The business’s 50 day simple moving average is $96.24 and its 200-day simple moving average is $96.86.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, September 3rd. BMO Capital Markets started coverage on shares of HealthEquity in a research note on Thursday, November 13th. They set a “market perform” rating and a $100.00 target price for the company. KeyCorp decreased their target price on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada raised their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $119.00.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total value of $156,840.00. Following the transaction, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. The trade was a 1.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 10,781 shares of company stock valued at $1,016,707. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Larson Financial Group LLC boosted its position in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares during the period. iSAM Funds UK Ltd purchased a new stake in HealthEquity in the 3rd quarter worth about $117,000. Merit Financial Group LLC boosted its position in HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after acquiring an additional 172 shares during the period. Advisory Services Network LLC purchased a new position in HealthEquity during the 3rd quarter valued at about $207,000. Finally, Focus Partners Wealth acquired a new position in shares of HealthEquity in the 3rd quarter valued at about $213,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.